publication venue for
- Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study. 57:370-381. 2018
- Evaluation of damage in giant cell arteritis. 57:322-328. 2018
- Evaluating the design and reporting of pragmatic trials in osteoarthritis research. 57:59-63. 2018
- Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues. 56:kew441-kew441. 2017
- BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics. 56:313-316. 2017
- Calcinosis is associated with digital ischaemia in systemic sclerosis—a longitudinal study. 55:2148-2155. 2016
- Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis. 54:1351-1359. 2015
- What drives the comparative effectiveness of biologics vs methotrexate in rheumatoid arthritis? Meta-regression and graphical inspection of suspected clinical factors. 53:1264-1273. 2014
- The prevalence of vertebral fracture on vertebral fracture assessment imaging in a large cohort of patients with rheumatoid arthritis. 53:821-827. 2014
- Unilateral vs bilateral symptomatic knee osteoarthritis: associations between pain intensity and function. 52:2229-2237. 2013
- Increased production of IL-5 and dominant Th2-type response in airways of Churg–Strauss syndrome patients. 51:1887-1893. 2012
- von Willebrand factor antigen--a possible biomarker of disease activity in childhood central nervous system vasculitis?. 51:1838-1845. 2012
- Predictors of response to intra-articular steroid injection in psoriatic arthritis. 49:1367-1373. 2010
- Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. 49:1399-1405. 2010
- Time and predictors of response to tumour necrosis factor- blockers in psoriatic arthritis: an analysis of a longitudinal observational cohort. 49:1361-1366. 2010
- Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg–Strauss syndrome. 48:1202-1207. 2009
- Reports of abnormal cervical cancer screening tests in systemic sclerosis. 48:149-151. 2009
- Quality of randomized clinical trials in juvenile idiopathic arthritis. 47:640-645. 2008
- Arthritis risk after acute bacterial gastroenteritis. 47:200-204. 2008
- Developing a disease activity tool for systemic-onset juvenile idiopathic arthritis by international consensus using the Delphi approach. 44:1574-1578. 2005
- What does ‘active disease’ mean? patient and parent perceptions of disease activity in the systemic arthritis form of juvenile idiopathic arthritis (SO-JIA). 44:796-799. 2005
- Acupuncture for the alleviation of lateral epicondyle pain: a systematic review. 43:1085-1090. 2004
- Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals. 42:263-267. 2003
- Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi‐national survey. 39:556-559. 2000
- Characteristics of septic arthritis in human immunodeficiency virus- infected haemophiliacs versus other risk groups. 38:139-142. 1999
- Radiological assessment in psoriatic arthritis. 37:760-765. 1998
- Auranofin. 36:560-572. 1997
- Salmon calcitonin nasal spray in the prevention of corticosteroid- induced osteoporosis. 36:255-259. 1997
- SENSITIVITY AND SPECIFICITY OF DIFFERENT DIAGNOSTIC CRITERIA FOR BEHÇET'S DISEASE ACCORDING TO THE LATENT CLASS APPROACH. 34:932-935. 1995
- Successful Treatment of Gold-induced Aplastic Anaemia with Granulocyte Macrophage Colony Stimulating Factor. 31:428-429. 1992
- Prior Score Availability: Observations Using The WOMAC Osteoarthritis Index. 30:150-151. 1991
- INTERACTION OF IBUPROFEN AND WARFARIN ON PRIMARY HAEMOSTASIS. 28:46-49. 1989
- INCREASED INTESTINAL PERMEABILITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: A SIDE-EFFECT OF ORAL NONSTEROIDAL ANTI-INFLAMMATORY DRUG THERAPY?. 26:103-107. 1987
- PUNCHED-CARD AID IN RHEUMATOLOGICAL DIAGNOSIS. 26:46-50. 1987
- Reinforcement of Bias in the Medical Literature: Nonsteroidal Anti-inflammatory Drugs and the Stomach—a Case in Poin. 26:231-232. 1987
- The effect of rheumatoid arthritis–associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis. kew474-kew474.
- A RANDOMIZED DOUBLE-BLIND TRIAL OF ABATACEPT AND GLUCOCORTICOIDS FOR THE TREATMENT OF TAKAYASU'S ARTERITIS 2017
- ARTERIAL LESIONS IN GIANT CELL ARTERITIS 2017
- DISCREPANCIES BETWEEN CLINICAL- AND IMAGING-BASED ASSESSMENTS OF DISEASE ACTIVITY IN TAKAYASU'S ARTERITIS 2017
- IDENTIFICATION OF FUNCTIONAL AND EXPRESSION POLYMORPHISMS ASSOCIATED WITH RISK FOR ANTI-NEUTROPHIL CYTOPLASMIC AUTOANTIBODY-ASSOCIATED VASCULITIS 2017
- LATE-ONSET RELAPSE IN PATIENTS WITH SYSTEMIC VASCULITIS 2017
- PATIENT REPORTED OUTCOMES AS PREDICTORS OF FLARES IN TAKAYASU ARTERITIS 2017
- PLASMA EXCHANGE AND GLUCOCORTICOID DOSING IN THE TREATMENT OF ANTI-NEUTROPHIL CYTOPLASM ANTIBODY ASSOCIATED VASCULITIS: BASELINE CHARACTERISTICS OF A RANDOMIZED CONTROLLED TRIAL (PEXIVAS) 2017
- PREVALENCE OF IMMUNOFLUORESCENT DEPOSITS IN ANCA ASSOCIATED VASCULITIS 2017
- SPUTUM ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) IN EOSINOPHILIC GRANULAMATOSIS AND POLYANGIITIS (EGPA) 2017
- THE STEROID TAPERING IN ANCA VASCULITIS EVALUATION STUDY (STAVE) 2: A SYSTEMATIC REVIEW AND META-ANALYSIS 2017
- TWO INTERNATIONAL MULTIREGIONAL INVESTIGATOR INITIATED CLINICAL TRIALS ON VASCULITIS: COLLABORATION WITH EUVAS, VCRC AND NATIONWIDE VASCULITIS STUDY GROUPS OF JAPAN 2017
- URINARY EPIDERMAL GROWTH FACTOR AS A BIOMARKER OF RENAL INVOLVEMENT IN ANCA-ASSOCIATED VASCULITIS 2017
- UTILITY OF MEASUREMENTS OF URINARY SOLUBLE CD163 & MCP1 IN THE IDENTIFICATION OF SUBTLE RENAL FLARES IN ANCA VASCULITIS 2017
- ACHIEVING MINIMAL DISEASE ACTIVITY (MDA) CRITERIA DECREASES PROGRESSION OF JOINT DAMAGE IN PSORIATIC ARTHRITIS 2009
- FREQUENCY AND PREDICTORS OF MINIMAL DISEASE ACTIVITY IN AN OBSERVATIONAL PSA COHORT 2009
- Gout in paleopathology; The elusive nature of urate 2007